Alkermes submits new long-acting, injectable schizophrenia drug for U.S. approval
August 25, 2014 at 13:39 PM EDT
Irish drug company Alkermes has submitted its long-acting, injectable reformulation of Abilify, aimed at helping schizophrenics stay on their medication, for U...